The management of biosafety risk in clinical laboratory of hospital during the outbreak of 2019 Novel Coronavirus disease / 中华检验医学杂志
Chinese Journal of Laboratory Medicine
; (12): E010-E010, 2020.
Article
en Zh
| WPRIM
| ID: wpr-811634
Biblioteca responsable:
WPRO
ABSTRACT
During the outbreak of coronavirus disease-19 (COVID-19), the clinical laboratories of hospitals designated for the disease treatment is undertaking a lot of clinical testing work of infectious specimens. How to manage the biosafety risk is a major problem that the clinical laboratory and the nosocomial infection control department are facing. This article introduces the hierarchical prevention and control biosafety measures in the clinical laboratory from the perspective of the laboratory, with a view to provide reasonable and feasible methods for the clinical laboratories of hospitals at various levels during the outbreak.
Texto completo:
1
Base de datos:
WPRIM
Tipo de estudio:
Etiology_studies
Idioma:
Zh
Revista:
Chinese Journal of Laboratory Medicine
Año:
2020
Tipo del documento:
Article